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Objective(s): The main goal of the current research was to examine the effects of Berberine (BBR) on 
apoptotic signaling and hippocampal oxidative stress induced by common carotid artery occlusion.
Materials and Methods: Chronic cerebral hypoperfusion (CCH) model was created by occluding the two 
common carotid arteries (two-vessel occlusion [2VO]) permanently. BBR (50 and 100 mg/kg/daily) was 
intra-gastrically administered to ischemic rats. Neuronal survival was evaluated by Nissl staining. The levels 
of malondialdehyde (MDA) and antioxidant enzymes, including catalase (CAT) and superoxide dismutase 
(SOD), along with the activities of caspase 3 were estimated in the hippocampus 2 month after treating the 
rats with 2VO.
Results: According to findings of the present research, the BBR therapy inhibited the neuro-
degeneration of hippocampus. BBR also significantly decreased the amount of MDA and activity 
of caspase 3 in the hippocampus. Furthermore, the administration of BBR alleviated the lowered 
activities of SOD and CAT after 2VO surgery.
Conclusion: The antioxidant and antiapoptotic properties of BBR might play important roles in 
improving functional outcomes and might have significant neuroprotective effects on the CCH damage.
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Introduction
Cerebral ischemia is the most prevalent cause 
of disability, as well as the most important cause of 
mortality, especially in the developed countries. There 
are several types of ischemia such as the acute brain 
ischemia, which is classified in two types of global and 
focal ischemia (1). Focal cerebral ischemia happens 
when the blood flow is reduced in a particular area 
of brain. Symptoms are different depending on the 
region of damaged brain (2). Global brain ischemia is 
a disorder, where the entire blood flow to the brain is 
stopped or reduced (1). This is commonly triggered by 
cardiac arrest. Chronic cerebral hypoperfusion (CCH) is 
a condition in which the flow of blood toward the brain 
mildly reduces for a long time (3). It is revealed that 
the CCH is a pathophysiological mechanism that is both 
conventional and fundamental, and is regarded as a 
main factor for cognitive deterioration and degenerative 
procedures that results in dementia (3, 4). CCH is also 
an etiological determinant of Alzheimer’s disease (AD) 
(4). The hippocampal region is one of the main cerebral 
areas, which performs a notable role on learning and 
memory. This part of the brain, especially the CA1 
pyramidal neurons, is very vulnerable to ischemic insults 
(5). Various types of cerebral ischemia  have almost the 
same harmful mechanisms. Increased oxidative stress 
is a vital hypothesis about the origin of neurological 
impairment by vascular events (6, 7). 
A major evidence has suggested a connection 
between an increased creation of reactive oxygen 
species (ROS) and the expansion of neuronal mortality 
in different neurological problems, such as epilepsy, 
Alzheimer’s, brain ischemia and trauma (8). In addition, 
it was indicated that the higher oxidative stress during 
the brain ischemia might stimulate the beta-amyloid 
plaques formation. This probably indicated the 
association between AD and stroke (9). Severe oxidative 
stress during the cerebral ischemia can lead to the 
cell mortality by a necrotic or an apoptotic pathway. 
Consequently, antioxidants are able to decrease the 
brain impairment followed by ischemia (8, 10). 
Berberine (BBR) is the principal active compound, 
originally separated from therapeutic plants, including 
Phellodendri sp., Coptidis sp., and Berberis sp., with an 
extended past in the traditional Indian and Chinese 
medicine (11). Numerous researches have demonstrated 
several pharmacological and biochemical activities of 
BBR including the anti-inflammatory, anti-cancer, anti-
diabetic and anti-diarrhea actions (11). The obtained 
data from previous experiments also indicated that 
BBR might be used as a useful antioxidant in a variety of 
pathological conditions (12). It has also been revealed 
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that the BBR produces neuroprotective effects through 
its anti-inflammatory, antioxidative and anti-neuronal 
apoptosis pharmacological properties on the brain 
ischemia (12, 13). 
As such, the current research was first planned to 
evaluate the neuroprotective effects of BBR on the CCH 




Forty adult male Wistar rats weighting 200-250 g 
were used in this experiment (10 rats in each group). All 
rats were caged in a room with a monitored humidity of 
55 ± 5% and temperature of 24 ± 1°C with a typical 12-
hr light/dark cycle and were allowed to consume liberal 
amounts of food and water. All phases of the experiment 
were approved by the Ethics Committee of Yazd 
University of Medical Sciences and in line with the US 
National Institutes of Health Publication guidance for the 
maintenance and application of laboratory animals. All 
attempts were made to minimize the animals suffering. 
The rats were adjusted to the housing circumstances for 
seven days before experiment. The rats were randomly 
divided into four groups as follow: The CCH group, 
which were exposed to stable common carotid arteries 
occlusion, the sham group underwent the same process 
with no arterial ligation, the BBR treatment groups 
were treated with 50 and 100 mg/kg BBR (14) by intra-
gastric administration once a day for 2 month starting 
from surgery (Berberine hydrochloride, (Sigma-Aldrich 
Co), which was dissolved in normal saline (14).
Induction of 2VO
The permanent bilateral common carotid artery 
occlusion (2-vessel occlusion, 2VO) was performed to 
produce a model of CCH. Briefly, anesthetization of the 
Wistar rats was carried out by injection of xylazine (10 
mg/kg) and ketamine (90 mg/kg) intraperitoneally 
(IP). Before anesthesia, atropine sulfate (0.1 mg/kg) 
was intramuscularly injected to prevent any respiratory 
distress. The core body temperature was measured 
during and after the operation and kept steady by 
applying a heating pad linked to a rectal probe. After 
creating a ventral midline incision, the bilateral common 
carotid arteries were revealed, which were then softly 
disconnected from the carotid sheath and adjacent 
neural bundles and quietly ligated with 3–0 silk 
stitch. In order to decreasing mortality rates, arterials 
obstruction was carried out with a seven-day interval 
between right and left common carotids’ occlusion. The 
right common carotid artery was first occluded and 
seven days later, the left carotid was blocked as well 
(15, 16). After each surgery, the cut was sewed and 
the animals were returned to the cages after complete 
removal of anesthesia. 
Brain sample collection and histological assays
Sixty days following occlusion, four rats from each 
group were made completely anesthetized with chloral 
hydrate (350 mg/kg, IP) then perfused with 0.9% saline 
in a transcardial manner and 4% paraformaldehyde in 
0.1 M phosphate buffer (pH 7.4). Following that, the 
animals were beheaded and their brains were removed 
from the skull bone and fixed in the same solution 
for 2 days. Routine processing in paraffin were then 
made; briefly, the brains were dried with a rising series 
of ethanol, cleansed with xylene and set in paraffin, 
and then the brains were fixed in paraffin blocks for 
sectioning.
Nissl staining
The coronal sections with the thickness of 7 µm from 
hippocampus CA1 region (4 sections in each animal 
at 25 μm intervals) were prepared using a rotary 
microtome and transported to gelatinized slides. The 
sections dewaxed and rehydrated with xylene and 
ethanol and stained with 0.1% Cresyl Violet. Undamaged 
pyramidal neurons in CA1 area were calculated by 
a light microscope (400× magnification) and only 
pyramidal neurons with distinct nucleus and nucleoli 
were considered as healthy living cells (17). 
Immunohistochemistry
Immunohistochemical (IHC) staining was used to 
evaluate the activity of caspase 3. IHC was performed 
on 5-μm tissue sections. Briefly, 20 min were spent to 
incubate the tissue sections at 50 °C, followed by its 
drying with a downward series of alcohol, and exposing 
with 1% hydrogen peroxide in distilled water for 5 
minutes in a dark environment. To decrease the activity 
of endogenous peroxidase, after washing the antigens 
in phosphate-buffered saline (PBS) (pH=7.4), they were 
retrieved through autoclaving for 30 min in citrate buffer 
(C6H5Na3O7·2H2O, pH=6). Afterwards, the sections 
were incubated with primary antibody (ab13847) 
for the whole night at temperature of 4 °C. Optimum 
dilution was reported to be 1/300. In the next stage, the 
tissue sections were incubated in the goat polyclonal 
secondary antibody (HRP) (ab97051) for one hour at 
room temperature by adding 3, 3′- diaminobenzidine 
(DAB, Dako) to obtain an image of the antigen. Finally, 
hematoxylin (Sigma) was added to slightly counterstain 
tissue sections, and the sections were then dried in 
alcohol, cleansed in xylene (Sigma), and mounted for 
imagining. The primary antibody was not used in the 
negative control slide’s processing. Based on the data 
sheet, tissue of rat lung was applied as a positive control 
(18).
Brain sample collection and biochemical assays
Sixty days following occlusion, six animals from 
each group were completely anesthetized with chloral 
hydrate (350 mg/kg, IP). The rats were decapitated 
and both hippocampi from each rat were quickly 
removed. To homogenize, the tissues were exposed 
with ice-cold PBS to be 10% (w/v) homogenates, 
which were then centrifuged at 3000 rpm at 4 °C for 20 
min, then the supernatants were maintained at -80 °C 
for measurement of malondialdehyde (MDA) level in 
addition to superoxide dismutase (SOD), and catalase 
(CAT) activity. Concentration of protein was calculated 
using the Bradford method, where bovine serum 
albumin (BSA) was used as standard (19). 
Determination of MDA in tissue 
Brain homogenates were used to determine lipid 
peroxidation (LPO) by response of thiobarbituric 
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acid to MDA Assay Kit (Zellbio Co). The thiobarbituric 
acid reactive compound was produced following the 
combination of homogenate with the trichloroacetic 
acid, which was a red complex. The established red color 
of the subsequent response was estimated at 532 nm 
with a Nanodrape.
Catalase activity in hippocampus tissue 
Brain homogenates were used to determine the CAT 
activity by using CAT assay kit (Zellbio Co) in which H2O2 is 
used to produce H2O and O2. H2O2 attaches to molybdenic 
acid to create aclathrate, which was measured at 405 nm. 
The H2O2 content was then calculated and expressed as 
μmol/mg protein.
SOD activity in hippocampus tissue 
SOD assay kit (Zellbio Co) uses the superoxide anion 
for conversion to hydrogen peroxide and oxygen under 
enzymatic reaction conditions. SOD is one of the most 
effective antioxidant enzymes in the cell.
DPPH activity in hippocampus tissue
For DPPH activity assay, 0.0039 g of DPPH 
(1.1-diphenyl-2-picrylhydrazyl) powder was dissolved 
in 10 μl of methanol in this test. A diluent solution of 1 
to 9 in methanol was obtained from this stock solution. 
The aforementioned diluted solution was used in this 
test. The microtips were taken as protocols, and the 
following protocols were used:  380 μl PBS (100 mM) 
pH 7.4 + 20 μl Sample + 400 μl DPPH. This solution 
was placed in a dark environment at room temperature 
for about 30 min and read at 530 nm using absorbance 
Nanodrape. The following protocol was used to use Blank: 
380 µl phosphate buffer + 400 µl DPPH + 20 µl methanol. 
Sample absorption was calculated as follows: Activity [% 
of DPPH diminution] = [(A−Ax)/A]×100% (A= DPPH+ 
methanol, Ax= DPPH+ sample). Control A is the DPPH 
solution’s absorbance with methanol, and Sample A is the 
DPPH solution’s absorbance with tissue (20).
 
Statistical analysis
Statistical analysis was carried out using Graphpad 
prism 6 software. All data were analyzed using one-
way analysis of variance (ANOVA) and Tukey’s min 
test was used for comparison of differences between 
groups. Data were presented as Mean±SEM. Statistically, 
differences with P ≤0.05 were recognized as significant.
Results
Berberine increased neuronal density in the 
hippocampus of the 2VO animals
As presented in Figures 1 and 2, the neuronal density 
(the number of healthy neurons) in the hippocampal 
CA1 region of the CCH group was significantly lower 
compared to the sham group (P<0.001). After therapy 
with BBR at 50 and 100 mg/kg doses, the hippocampal 
neuronal density in BBR+CCH groups was considerably 
higher compared to the CCH group (P<0.01 and P<0.05).
 
Berberine decreases caspase 3 activity in the 
hippocampus of the 2VO animals
An increased activity of caspase 3 was observed in 
hippocampus of CCH group (P<0.01), while a decreased 
activity of caspase 3 was detected (P<0.05) in both 
treated BBR groups (Figure 3 and 4).  
  
BBR increases the level of MDA in the hippocampus of 
the 2VO animals
The levels of hippocampus MDA were considerably 
increased in the CCH group in comparison with the sham 

































Figure 1. The effects of berberine (BBR) on neuronal density in the 
hippocampus of the studied groups. Values represent means±SEM. 
***P<0.001 compared to sham (SH) group. ##P<0.01, #P<0.05 compared 
to chronic cerebral hypoperfusion (CCH) group
 
  
Figure 2. Nissl staining of hippocampal CA1 region. A: sham (SH) group, 
B: chronic cerebral hypoperfusion (CCH) group, C: CCH +berberine 
(BBR) 50 group, D: CCH+BBR 100 group. The black arrows indicate 
































Figure 3. The effects of berberine (BBR) on activity of caspase 3 in 
the hippocampus of the studied groups. Values represent means±SEM. 
**P<0.01 compared to sham group. #P<0.05 compared to chronic 
cerebral hypoperfusion (CCH) group
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MDA level in hippocampal tissue at both 50 and 100 
mg/kg treatment doses (P<0.001) in comparison with 
the CCH group (Figure 5). 
BBR increases the activities of SOD and CAT in the 
hippocampus of the 2VO animals
As presented in the Figure 6, the SOD and CAT 
activities were reduced in the CCH group, but they 
were insignificant. BBR treatment at the dose of 50 
mg/kg elevated the activities of SOD and CAT in the 
hippocampus of CCH-operated group (P<0.05); however, 
no significant difference was found between CCH and 
CCH+BBR100 groups (Figures 6A and 6B).
DPPH scavenging effect of hippocampus tissue of rats
Figure 7 illustrates the capability of the DPPH to 
scavenge homogenate hippocampus tissue. A considerable 
increase (P<0.05) was detected in the reduction of 
DPPH radical resulting from the scavenging ability of 
hippocampus tissue of BBR50-treated rats compared to 
the corresponding non-treated rats (Figure 7).
 
  Figure 4. The level of caspase 3 in the hippocampus of the studied groups. 
A: sham (SH) group, B: chronic cerebral hypoperfusion (CCH) group, C: 
CCH +berberine (BBR) 50 group, D: CCH+BBR 100 group. The black 








































Figure 5. The effects of berberine (BBR) on malondialdehyde (MDA) 
level in the hippocampus of the studied groups. Values represent 
means±SEM. ***P<0.001 compared to sham (SH) group. ###P<0.001 























































































Figure 6. The effects of berberine (BBR) on superoxide dismutase (SOD) (Figure A) and catalase (CAT) (Figure B) activity in the hippocampus of 








































Figure 7. The effects of berberine (BBR) on percent inhibition of free 
radicals in the hippocampus of the studied groups. Values represent 
means±SEM. *P<0.05 compared to sham (SH) group. #P<0.05 
compared to chronic cerebral hypoperfusion (CCH) group
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Discussion
It was found that dementia due to senility and 
AD was linked to the lower blood flow of brain (3). 
Vascular dementia is the second most prevalent reason 
for senile dementia (21). The permanent bilateral 
common carotid arteries occlusion is the most common 
method in rats to verify the effects of CCH, and it is 
also used as a verified model for neurodegenerative 
condition and cerebrovascular insufficiency states. 
This ischemia model is concomitant with progressive 
behavioral deficits and histological changes especially 
in the hippocampus (3). Previous studies revealed 
that the conspicuous loss of neurons especially in the 
hippocampal CA1 subfield started 2 weeks after 2VO 
induction and progressed with time. An increased rate 
of the hippocampal destruction was observed in 8-13 
weeks (3). An association was also observed between the 
impaired learning performance and a considerable loss 
of pyramidal cell in the region of CA1 (22). Numerous 
researches also found that the CCH-induced neuro-
degeneration was accompanied with the formation of 
ROS that is deadly to neurons at high concentrations 
(23). Low levels of ROS are generated and they can 
be monitored via endogenous antioxidants, including 
CAT, glutathione peroxidase (GPx), and SOD (3). Under 
pathological conditions such as ischemia, ROS is 
overproduced, antioxidant enzymes are inactivated, 
and antioxidants are consumed, so that mechanisms 
for natural defense are unable to protect neurons from 
oxidative damages (24). Excessive formation of ROS can 
lead to the oxidization of vital parts of cells such as DNA, 
proteins and membrane lipids, leading to apoptotic and 
necrotic cell death (23). MDA is the major product of 
unsaturated fatty acid peroxidation as a marker of LPO. 
According to reports, there was a greatly important raise 
in the average concentration of MDA in 2VO rats after 2 
month from starting surgery. Furthermore, the activity 
of antioxidant enzymes including GPx, SOD, and CAT 
reduced 2 month after the induction of 2VO in rats (3). 
Therefore, the therapeutic methods aiming to attenuate 
the oxidative stress including radical scavengers may 
be helpful in prolonging survival time of neurons 
during the cerebral ischemia (8, 24). The treatment 
with antioxidant has been assessed for a long duration 
as a tool for reducing the amount of damage caused by 
ischemic stroke with different levels of success (24). In 
another study by our group, we investigated the effects 
of BBR (50 mg/kg) on cognitive impairment and tissue 
apoptosis (16). 
In the current research, we evaluated the effect of BBR 
on the signaling pathway of apoptosis and oxidative stress 
in ischemic rats, and thus the results indicated that 2VO 
induction caused significant diminution in the SOD and 
CAT activities, and it might contribute to the occurrence 
of oxidative stress. We also observed a reduction of cell 
number in hippocampus and an increase in the LPO and 
caspase 3 activity in hippocampal tissue. Furthermore, 
the chronic administration of BBR significantly restored 
the changes in this tissue in the CCH group. 
BBR is a natural compound that has been safely 
administered to humans for long terms. There are 
several neuropharmacological features in BBR, including 
the capability of enhancing brain microcirculation and 
anti-neuronal apoptosis. This traditional drug has also 
a notable effect for preventing and inhibiting AD mostly 
via both beta-amyloid and cholinesterase pathways as 
well as its antioxidant capacities (11). 
In the present study, the MDA levels significantly 
reduced in BBR-treated groups, while there was an 
increase in the activities of CAT and SOD compared 
to the CCH group. Other studies were consistent with 
findings of the current study indicating that BBR may 
reduce the extreme formation of ROS and compensate 
antioxidant capacity (10, 25). 
Caspase 3 activity was another examined pathway 
in the present study. Caspase 3 activation was elevated 
in the group of CCH compared to the sham group. After 
treatment with BBR, the caspase 3 activity was nearly 
same to the control level. Significant evidence revealed 
that oxidative stress may be responsible for the apoptotic 
cell death caused by caspase during ischemia, and free 
radical scavengers decreased upregulation of caspase-3, 
fragmentation of DNA, and ultimate damages (26). 
Conclusion
This was the first study suggesting that beneficial 
efficacy of BBR on the CCH-induced oxidative stress 
and apoptosis in hippocampus might be ascribed to 
its antioxidant feature by reducing the LPO, increasing 
SOD and CAT activities as well as anti-apoptotic activity 
by modulating the caspase-3 activity level. These 
remarkable findings suggested that BBR must be further 
assessed in terms of its medical application.
Conflicts of Interest
The Authors declares that there is no conflict of interest.
Acknowledgment
This article was extracted from a university thesis 
of a student, which was funded by a grant provided 
by Shahid Sadoughi University of Medical Sciences, 
Neurobiomedical Research Center, Yazd, Iran. 
References
1. Harukuni I, Bhardwaj A. Mechanisms of brain injury after 
global cerebral ischemia. Neurologic clinics 2006; 24:1-21.
2. Gheibi S, Aboutaleb N, Khaksari M, Kalalian-Moghaddam 
H, Vakili A, Asadi Y, et al. Hydrogen sulfide protects the brain 
against ischemic reperfusion injury in a transient model of 
focal cerebral ischemia. J Mol Neurosci 2014; 54:264-270.
3. Farkas E, Luiten PG, Bari F. Permanent, bilateral common 
carotid artery occlusion in the rat: a model for chronic cerebral 
hypoperfusion-related neurodegenerative diseases. Brain Res 
Rev 2007; 54:162-180.
4. Lee JS, Im DS, An Y-S, Hong JM, Gwag BJ, Joo IS. Chronic 
cerebral hypoperfusion in a mouse model of Alzheimer’s 
disease: an additional contributing factor of cognitive 
impairment. Neurosci Lett 2011; 489:84-88.
5. Anand KS, Dhikav V. Hippocampus in health and disease: An 
overview. Ann Indian Acad Neurol 2012; 15:239-246.
6. Cobley JN, Fiorello ML, Bailey DM. 13 reasons why the brain 
is susceptible to oxidative stress. Redox Biology 2018; 15:490-
503.
7. Mehrjerdi FZ, Aboutaleb N, Habibey R, Ajami M, Soleimani 
M, Arabian M, et al. Increased phosphorylation of mTOR is 
involved in remote ischemic preconditioning of hippocampus 
in mice. Brain Res 2013; 1526:94-101.
8. Barnham KJ, Masters CL, Bush AI. Neurodegenerative 
159Iran J Basic Med Sci, Vol. 22, No. 2, Feb 2019 
The effect of berberine on hippocampus in CCH Pirmoradi et al.
diseases and oxidative stress. Nat Rev Drug Discov 2004; 
3:205-214.
9. Muche A, Arendt T, Schliebs R. Oxidative stress affects 
processing of amyloid precursor protein in vascular 
endothelial cells. PloS one 2017; 12:e0178127.
10. Rahbardar MG, Amin B, Mehri S, Mirnajafi-Zadeh SJ, 
Hosseinzadeh H. Rosmarinic acid attenuates development and 
existing pain in a rat model of neuropathic pain: an evidence of 
anti-oxidative and anti-inflammatory effects. Phytomedicine 
2018; 40:59-67.
11. Ye M, Fu S, Pi R, He F. Neuropharmacological and 
pharmacokinetic properties of berberine: a review of recent 
research. J Pharm Pharm Sci 2009; 61:831-837.
12. Gao F, Gao Y, Liu Y-f, Wang L, Li Y-j. Berberine exerts an 
anticonvulsant effect and ameliorates memory impairment 
and oxidative stress in a pilocarpine-induced epilepsy model 
in the rat. Neuropsychiatr Dis Treat 2014; 10:2139-2145.
13. Pires ENS, Frozza RL, Hoppe JB, de Melo Menezes B, Salbego 
CG. Berberine was neuroprotective against an in vitro model 
of brain ischemia: survival and apoptosis pathways involved. 
Brain Res 2014; 1557:26-33.
14. Moghaddam HK, Baluchnejadmojarad T, Roghani M, 
Khaksari M, Norouzi P, Ahooie M, et al. Berberine ameliorate 
oxidative stress and astrogliosis in the hippocampus of STZ-
induced diabetic rats. Mol Neurobiol 2014; 49:820-826.
15. Cechetti F, Worm PV, Pereira L, Siqueira IR, A Netto C. The 
modified 2VO ischemia protocol causes cognitive impairment 
similar to that induced by the standard method, but with a 
better survival rate. Braz J Med Biol Res 2010; 43:1178-1183.
16. Aski ML, Rezvani ME, Khaksari M, Hafizi Z, Pirmoradi Z, 
Niknazar S, et al. Neuroprotective effect of berberine chloride 
on cognitive impairment and hippocampal damage in 
experimental model of vascular dementia. Iran J Basic Med Sci 
2018; 21:53-58.
17. Mehrjerdi FZ, Aboutaleb N, Pazoki-Toroudi H, Soleimani M, 
Ajami M, Khaksari M, et al. The protective effect of remote renal 
preconditioning against hippocampal ischemia reperfusion 
injury: role of KATP channels. J Mol Neurosci 2015; 57:554-
560.
18. Chen W, Wei S, Yu Y, Xue H, Yao F, Zhang M, et al. Pretreatment 
of rats with increased bioavailable berberine attenuates 
cerebral ischemia-reperfusion injury via down regulation of 
adenosine-5′ monophosphate kinase activity. Eur J Pharmacol 
2016; 779:80-90.
19. Bradford MM. A rapid and sensitive method for the 
quantitation of microgram quantities of protein utilizing the 
principle of protein-dye binding. Anal Biochem 1976; 72:248-
254.
20. Gülçin İ. Antioxidant activity of caffeic acid (3, 
4-dihydroxycinnamic acid). Toxicology 2006; 217:213-220.
21. Scott KR, Barrett AM. Dementia syndromes: evaluation and 
treatment. Expert Rev Neurother 2007; 7:407-422.
22. Atlasi MA, Naderian H, Noureddini M, Fakharian E, Azami 
A. Morphology of Rat Hippocampal CA1 neurons following 
modified two and four-vessels global ischemia models. Arch 
Trauma Res 2013; 2:124-128.
23. Zhang G-L, Deng J-P, Wang B-H, Zhao Z-W, Li J, Gao L, et 
al. Gypenosides improve cognitive impairment induced 
by chronic cerebral hypoperfusion in rats by suppressing 
oxidative stress and astrocytic activation. Behav Pharmacol 
2011; 22:633-644.
24. Rahal A, Kumar A, Singh V, Yadav B, Tiwari R, Chakraborty 
S, et al. Oxidative stress, prooxidants, and antioxidants: 
the interplay. BioMed Research International 2014; 2014; 
761264-761283.
25. Dong S, Yasui N, Negishb H, Kishimoto A, Sun J, Ikeda 
K. Increased oxidative stress in cultured 3T3-L1 cells was 
attenuated by berberine treatment. Nat Prod Commun 2015; 
10:895-897.
26. Smith JA, Park S, Krause JS, Banik NL. Oxidative stress, DNA 
damage, and the telomeric complex as therapeutic targets in 
acute neurodegeneration. Neurochem Int 2013; 62:764-775.
